advertisement
Zangwill LM 35
Showing records 1 to 25 | Display all abstracts from Zangwill LM78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Weinreb RN
Ophthalmology 2018; 125: 1874-1885
78939 Racial Differences in Rate of Change of Spectral-Domain Optical Coherence Tomography-Measured Minimum Rim Width and Retinal Nerve Fiber Layer Thickness
Bowd C
American Journal of Ophthalmology 2018; 196: 154-164
78496 Performance of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma
Wu Z
American Journal of Ophthalmology 2018; 196: 10-17
78943 Macular Pigment and Visual Function in Patients With Glaucoma: The San Diego Macular Pigment Study
Daga FB
Investigative Ophthalmology and Visual Science 2018; 59: 4471-4476
78513 Optic disc microvasculature dropout in primary open-angle glaucoma measured with optical coherence tomography angiography
Akagi T; Zangwill LM
PLoS ONE 2018; 13: e0201729
78496 Performance of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma
Medeiros FA
American Journal of Ophthalmology 2018; 196: 10-17
78943 Macular Pigment and Visual Function in Patients With Glaucoma: The San Diego Macular Pigment Study
Ogata NG
Investigative Ophthalmology and Visual Science 2018; 59: 4471-4476
78939 Racial Differences in Rate of Change of Spectral-Domain Optical Coherence Tomography-Measured Minimum Rim Width and Retinal Nerve Fiber Layer Thickness
Zangwill LM
American Journal of Ophthalmology 2018; 196: 154-164
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Liebmann JM
Ophthalmology 2018; 125: 1874-1885
78943 Macular Pigment and Visual Function in Patients With Glaucoma: The San Diego Macular Pigment Study
Medeiros FA
Investigative Ophthalmology and Visual Science 2018; 59: 4471-4476
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Cioffi GA
Ophthalmology 2018; 125: 1874-1885
78939 Racial Differences in Rate of Change of Spectral-Domain Optical Coherence Tomography-Measured Minimum Rim Width and Retinal Nerve Fiber Layer Thickness
Weinreb RN
American Journal of Ophthalmology 2018; 196: 154-164
78513 Optic disc microvasculature dropout in primary open-angle glaucoma measured with optical coherence tomography angiography
Shoji T
PLoS ONE 2018; 13: e0201729
78496 Performance of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma
Weinreb RN; Zangwill LM
American Journal of Ophthalmology 2018; 196: 10-17
78943 Macular Pigment and Visual Function in Patients With Glaucoma: The San Diego Macular Pigment Study
Moran R
Investigative Ophthalmology and Visual Science 2018; 59: 4471-4476
78513 Optic disc microvasculature dropout in primary open-angle glaucoma measured with optical coherence tomography angiography
Suh MH
PLoS ONE 2018; 13: e0201729
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Goldberg I
Ophthalmology 2018; 125: 1874-1885
78939 Racial Differences in Rate of Change of Spectral-Domain Optical Coherence Tomography-Measured Minimum Rim Width and Retinal Nerve Fiber Layer Thickness
Girkin CA
American Journal of Ophthalmology 2018; 196: 154-164
78943 Macular Pigment and Visual Function in Patients With Glaucoma: The San Diego Macular Pigment Study
Morris J
Investigative Ophthalmology and Visual Science 2018; 59: 4471-4476
78939 Racial Differences in Rate of Change of Spectral-Domain Optical Coherence Tomography-Measured Minimum Rim Width and Retinal Nerve Fiber Layer Thickness
Fazio MA
American Journal of Ophthalmology 2018; 196: 154-164
78513 Optic disc microvasculature dropout in primary open-angle glaucoma measured with optical coherence tomography angiography
Saunders LJ
PLoS ONE 2018; 13: e0201729
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Brandt JD
Ophthalmology 2018; 125: 1874-1885
78939 Racial Differences in Rate of Change of Spectral-Domain Optical Coherence Tomography-Measured Minimum Rim Width and Retinal Nerve Fiber Layer Thickness
Liebmann JM
American Journal of Ophthalmology 2018; 196: 154-164
78513 Optic disc microvasculature dropout in primary open-angle glaucoma measured with optical coherence tomography angiography
Yarmohammadi A
PLoS ONE 2018; 13: e0201729
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Johnson CA
Ophthalmology 2018; 125: 1874-1885
